Manila Times Business
Applied Biologics Announces Completion of Planned Enrollment Activities in the CAMPX Randomized Controlled Trial Evaluating XWRAP®
SCOTTSDALE, Ariz., June 17, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the completion of planned enrollment activities in the CAMPX randomized controlled clinical trial evaluating XWRAP® in the treatment of chronic diabetic foot ulcers. The CAMPX Trial is a prospective, randomized, controlled, multicenter study conducted across 23 SerenaGroup and affiliated r
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →